Neko Health is a Swedish health-tech company, founded in 2018, that develops full-body scanning technology for preventive healthcare and early disease detection. Its core product, the Neko Body Scan, maps millions of data points across skin, cardiovascular, metabolic, and eye health systems in minutes. The service combines automated analysis with a physician consultation. To date, the company reports that approximately 1% of scanned patients are identified with serious, potentially life-threatening conditions, while 7% discover significant health issues requiring attention.
The company has scaled to over 500 employees and completed more than 10,000 scans, with a global waitlist exceeding 300,000 people - achieved without paid marketing. Its 80% member rebooking rate and high advance payment rates suggest strong user retention. A recent funding round of €260 million valued the company at $1.8 billion.
Neko Health operates clinics in Stockholm, London, Manchester, and Birmingham, with an expansion to New York City planned for 2026. The firm was co-founded by Daniel Ek, founder of Spotify, and its technical work spans domains including data point mapping, detailed skin mapping, and inflammation level analysis.
